Dow Jones

44,296.51

0.97%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
USOTC
Alseres Pharmaceuticals Inc (CE) (ALSE)
Alseres Pharmaceuticals Inc (CE) (ALSE) Noticias

ALSE

Alseres Pharmaceuticals (CE) (ALSE)

Alseres Pharmaceuticals Inc (CE)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:ALSE

1

Fecha	Hora	Fuente	Título	Símbolo	Compañía
21/11/2014	15:10	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
18/11/2014	14:09	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
14/08/2014	07:09	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
16/05/2014	08:46	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
10/04/2014	07:52	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
31/03/2014	16:00	Edgar (US Regulatory)	Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
31/03/2014	16:00	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
28/01/2013	13:40	Edgar (US Regulatory)	Definitive Materials Filed by Investment Companies. (497)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
28/01/2013	13:40	Edgar (US Regulatory)	Annual Report (management Company) (nsar-b)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
28/01/2013	13:37	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
08/01/2013	09:21	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
14/11/2012	05:08	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
29/03/2012	15:50	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
07/02/2012	15:11	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
27/12/2011	15:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
27/12/2011	15:00	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
07/06/2011	15:56	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
03/01/2011	14:46	Edgar (US Regulatory)	Amended tender offer statement by Issuer (SC TO-I/A)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
28/05/2010	15:53	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
30/04/2010	09:50	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
10/11/2009	15:44	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (D)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
17/07/2009	08:31	Edgar (US Regulatory)	(25-NSE)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)